Ascendiant Capital Maintains Buy on Aemetis, Lowers Price Target to $19
Benzinga Newsdesk 2 years ago
NewsPrice TargetAnalyst Ratings
Ascendiant Capital analyst Edward Woo maintains Aemetis (NASDAQ:AMTX) with a Buy and lowers the price target from $20 to $19.
Ascendiant Capital analyst Edward Woo maintains Aemetis (NASDAQ:AMTX) with a Buy and lowers the price target from $20 to $19.